Fig. 4.
Low ALDH2 expression predicts a poor prognosis in liver cancer. a Boxplot representing the overall variation in XRCC1 and ALDH2 mRNA levels in liver cancers (Oncomine). b Kaplan-Meier analysis of the 5-year overall survival of liver cancer patients (TCGA) stratified for XRCC1 mRNA levels (cut at the median). c Kaplan-Meier analysis of the 5-year overall survival of liver cancer patients (TCGA) stratified for ALDH2 mRNA levels (cut at the median)